Quality | 2019.11.25
Cannabinoid Biosciences, Inc. Announces Acquisition of CBD Assets CannabidiolHemp
Cannabinoid Biosciences, Inc. announces its acquisition of CannabidiolHemp (CannabidiolHemp.net), a premium CBD quality aggregator and standard validator. This is the beginning of many acquisitions to build Cannabinoid Biosciences, Inc. and its parent company, Kid Castle into a major “pure-play” CBD operation in the United States and Canada. Starting with CBD distribution channel, like CannabidiolHemp, Cannabinoid Biosciences/Kid Castle is well on its way to become the most vertically integrated “pure-play” CBD operation in the United States and Canada. Once we have gained a good footing on the CBD distribution channel, we would then move our acquisition machine towards the CBD supply-chain to ensure full vertical integration. Control of CannabidiolHemp will help Kid Castle in establishing a solid position to lead the standardization of Farm Bill compliant hemp-based medicinal products to serve the rapidly growing CBD market – a segment some analysts have predicted will soar to $11 billion by 2026.
(PRWeb November 26, 2019)
Read the full story at https://www.prweb.com/releases/cannabinoid_biosciences_inc_announces_acquisition_of_cbd_assets_cannabidiolhemp/prweb16740411.htm
For more information, please visit
https://www.prweb.com/releases/cannabino[...]nabidiolhemp/prweb16740411.htm
